Fuso Teiyaku (Qingdao) Co., Ltd. is the research and production base invested in China by Japan Teikoku Seiyaku Group, registered and founded on June 18, 2003 in Qingdao high-tech industrial park. The Company mainly uses transdermal absorption technology to be engaged in production and research on clinical paster for external use and water-soluble gel preparation for external use, aiming to create the first brand of transdermal technology in China.
Investor—Japan Teikoku Seiyaku Group was established in 1848, the biggest specialized production factory of paster for external use in Japan, and its research, development and production capacity of the transdermal water gel absorbed preparation is leading in the world; there are hundreds of paster products for external use, with an annual affixed cloth (10cm × 14cm) of about 1.2 billion pasters. Teikoku Seiyaku Group implements strict quality management system, and the pharmaceutical factory has passed the Ministry of Welfare (Japan), the FDA and the European health department GMP certifications, the products have been sold to more than 40 countries and regions in Europe, America and Asia, and the sales volume and exports have been in the first place for many years in Japan.
Fuso Teiyaku (Qingdao) Co., Ltd. completely introduces Japan Teikoku Seiyaku Group half a century of research and production technology, advanced production equipment and production technology for transdermal preparation as well as strict quality management system, and the product series cover drugs, medical equipment, cosmetics and daily necessities; at present, it has obtained drugs, medical equipment, cosmetics production licenses, imported paster subpackaging of GMP authentication and ISO9001 authentication and ISO 13485 authentication, and the products are exported to Japan, America, Britain, Oceania countries and African countries and regions.
Fuso Teiyaku (Qingdao) Co., Ltd., with its unique transdermal water gel technology as the basis, strengthens the fusion and exchange with domestic water gel technology research institutions, builds the transdermal research and development institution with the leading advantages in China and contributes to the improvement of quality management system. On the one hand, it has increased the research and development of independent products and the development of domestic market, and the market share has increased year by year; On the other hand, it strengthens technical and sales cooperation with the well-known domestic pharmaceutical enterprises such as Yunnan Baiyao, Xiuzheng Pharmaceutical, Wantong Pharmaceutical, LingRui Pharmaceutical, Harbin Pharmaceutical Group and the domestic well-known pharmacy chain – China Nepstar Chain Drugstore, which has achieved good economic and social benefits. In the future, the Company will be devoted to the research and development on Type II medical equipment and pharmaceuticals, planning to build the largest production base of water gel transdermal absorption preparation for external use in China.
